Alpha Lipoic Acid Market to witness over 6% growth during the projected timespan.

Growing consumer consciousness towards healthy living standard has subsequently propelled dietary supplements demand which is expected to generate growth avenues for the alpha lipoic acid market during the forecast period. Growing geriatric population primarily in Latin America and Asia Pacific is another factor responsible for the rising dietary supplements demand to maintain healthy living standards with lesser dependency on physical workout.

"Alpha Lipoic Acid Market is poised to exceed USD 19 million by 2024; according to a new research report.”

Prevailing trends for diabetic people primarily in China, Australia and India has resulted in rising product demand to manufacture medical drugs which in turn will boost alpha lipoic acid market by 2024. For instance, in china approximately 20.7 million people were suffering from diabetes in 2000 which is expected to increase at a faster pace and reach over 42.3 million by 2030.

Request for Sample Copy of this Report@ https://www.gminsights.com/request-sample/detail/1605

Limited product use owing to its several side effects including itching sensation on the skin, nausea, etc., is probable to hamper the global alpha lipoic acid market in the near future. It is not advisable for pregnant women, thyroid patients, Vitamin B1 deficient people to consume product due to adverse side effects which is likely to hamper alpha lipoic acid market by 2024. Furthermore, availability of several product substitutes namely B-alanine, chromium, Coenzyme Q10, etc. in market is likely to impede the business by 2024.

R-lipoic acid led the global alpha lipoic acid market and accounted for over 80% business in 2016. Product is organically active water and fat-soluble antioxidant which present naturally in plants, animals and body. However, it occurs as a racemic mixture of R-(natural) and S-(unnatural) form which is commercially available in the market. R-lipoic acid is effective in treating diabetes and is an excellent neuroprotective agent.

Medical drugs segment is foreseeable to grow at a CAGR close to 6% by 2024. Robust product demand to manufacture various drugs which can treat terminal disorders such as diabetes, nerve pain, cataract formation, cancer treatment, blood sugar level, skin discoloration, HIV, healing wounds and coronary artery bypass graft (CABG) surgery will generate plentiful growth aspects for the medical drugs segment which in turn will drive alpha lipoic acid market by 2024.

Browse key industry insights from the report, “alpha lipoic acid market” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/alpha-lipoic-acid-market

Asia Pacific is anticipated to grow at a CAGR of over 7% over the projected time spell. This is primarily attributed to rising pace of diabetic patients and other lethal diseases including liver ailment, HIV, cancer treatment, neuro disorder, migraine treatment, etc. in the region which will help generate significant revenue for the alpha lipoic acid market by 2024. For instance, diabetes health expenditure in China was ranked 2nd in 2015 with USD 51 billion which is expected to rise to USD 72 billion by 2040.

The overall alpha lipoic acid market is highly fragmented with major companies accounting for roughly 35% of the total industry share in 2016. Significant business share contributors are Shanghai Shyndec (Modern) Pharmaceuticals, Alzchem, Life Extension, Swanson Health, Now Health Group, Sabinsa Corporation, Infa Group and HiMedia Laboratories.

Request for Inquiry before buying this Report @ https://www.gminsights.com/inquiry-before-buying/1605

Alpha lipoic acid market research report includes in-depth coverage of the industry, with estimates & forecast in terms of volume in tons and revenue in USD thousand from 2013 to 2024, for the following segments:
Alpha Lipoic Acid market by product
o R-lipoic acid
o S-lipoic acid
Alpha Lipoic Acid market by application
o Dietary supplement
o Slimming products
o Medical drugs
o Others
The above information is provided on a regional and country basis for the following:
o North America
 U.S.
 Canada
o Europe
 Germany
 UK
 France
 Spain
 Italy
o Asia Pacific
 China
 India
 Japan
 Australia
 Indonesia
 Malaysia
o Latin America
 Brazil
 Mexico
o Middle East & Africa
 South Africa
 GCC

Report Content
Chapter 6. Alpha Lipoic Acid Market, By Region
6.1. Global alpha lipoic acid market share by region, 2016 & 2024
6.2. North America
6.2.1. North America market estimates and forecast, 2013 - 2024
6.2.2. North America market estimates and forecasts by product, 2013 – 2024
6.2.3. North America market estimates and forecasts by application, 2013 – 2024
6.2.4. U.S.
6.2.4.1. U.S market estimates and forecast, 2013 - 2024
6.2.4.2. U.S. market estimates and forecasts by product, 2013 – 2024
6.2.4.3. U.S. market estimates and forecasts by application, 2013 – 2024
6.2.5. Canada
6.2.5.1. Canada market estimates and forecast, 2013 - 2024
6.2.5.2. Canada market estimates and forecasts by product, 2013 – 2024
6.2.5.3. Canada market estimates and forecasts by application, 2013 – 2024
6.3. Europe
6.3.1. Europe market estimates and forecast, 2013 - 2024
6.3.2. Europe market estimates and forecasts by product, 2013 – 2024
6.3.3. Europe market estimates and forecasts by application, 2013 – 2024
6.3.4. UK
6.3.4.1. UK market estimates and forecast, 2013 – 2024
6.3.4.2. UK market estimates and forecasts by product, 2013 – 2024
6.3.4.3. UK market estimates and forecasts by application, 2013 – 2024
6.3.5. Germany
6.3.5.1. Germany market estimates and forecast, 2013 - 2024
6.3.5.2. Germany market estimates and forecasts by product, 2013 – 2024
6.3.5.3. Germany market estimates and forecasts by application, 2013 – 2024
6.3.6. France
6.3.6.1. France market estimates and forecast, 2013 - 2024
6.3.6.2. France market estimates and forecasts by product, 2013 – 2024
6.3.6.3. France market estimates and forecasts by application, 2013 – 2024
6.3.7. Spain
6.3.7.1. Spain market estimates and forecast, 2013 - 2024
6.3.7.2. Spain market estimates and forecasts by product, 2013 – 2024
6.3.7.3. Spain market estimates and forecasts by application, 2013 – 2024
6.3.8. Italy
6.3.8.1. Italy market estimates and forecast, 2013 - 2024
6.3.8.2. Italy market estimates and forecasts by product, 2013 – 2024
6.3.8.3. Italy market estimates and forecasts by application, 2013 – 2024
6.4. Asia Pacific
6.4.1. Asia Pacific market estimates and forecast, 2013 - 2024
6.4.2. Asia Pacific market estimates and forecasts by product, 2013 – 2024
6.4.3. Asia Pacific market estimates and forecasts by application, 2013 – 2024
6.4.4. China
6.4.4.1. China market estimates and forecast, 2013 - 2024
6.4.4.2. China market estimates and forecasts by product, 2013 – 2024
6.4.4.3. China market estimates and forecasts by application, 2013 – 2024
6.4.5. Japan
6.4.5.1. India market estimates and forecast, 2013 - 2024
6.4.5.2. India market estimates and forecasts by product, 2013 – 2024
6.4.5.3. India market estimates and forecasts by application, 2013 – 2024
6.4.6. India
6.4.6.1. Japan market estimates and forecast, 2013 - 2024
6.4.6.2. Japan market estimates and forecasts by product, 2013 – 2024
6.4.6.3. Japan market estimates and forecasts by application, 2013 – 2024
6.4.7. Australia
6.4.7.1. Australia market estimates and forecast, 2013 - 2024
6.4.7.2. Australia market estimates and forecasts by product, 2013 – 2024
6.4.7.3. Australia market estimates and forecasts by application, 2013 – 2024
6.4.8. Indonesia
6.4.8.1. Indonesia market estimates and forecast, 2013 - 2024
6.4.8.2. Indonesia market estimates and forecasts by product, 2013 – 2024
6.4.8.3. Indonesia market estimates and forecasts by application, 2013 – 2024
6.4.9. Thailand
6.4.9.1. Thailand market estimates and forecast, 2013 - 2024
6.4.9.2. Thailand market estimates and forecasts by product, 2013 – 2024
6.4.9.3. Thailand market estimates and forecasts by application, 2013 – 2024
6.4.10. Malaysia
6.4.10.1. Malaysia market estimates and forecast, 2013 - 2024
6.4.10.2. Malaysia market estimates and forecasts by product, 2013 – 2024
6.4.10.3. Malaysia market estimates and forecasts by application, 2013 – 2024
6.5. Latin America (LATAM)
6.5.1. LATAM market estimates and forecast, 2013 - 2024
6.5.2. LATAM market estimates and forecasts by product, 2013 – 2024
6.5.3. LATAM Market estimates and forecasts by application, 2013 – 2024
6.5.4. Brazil
6.5.4.1. Brazil market estimates and forecast, 2013 - 2024
6.5.4.2. Brazil market estimates and forecasts by product, 2013 – 2024
6.5.4.3. Brazil market estimates and forecasts by application, 2013 – 2024
6.5.5. Mexico
6.5.5.1. Mexico market estimates and forecast, 2013 - 2024
6.5.5.2. Mexico market estimates and forecasts by product, 2013 – 2024
6.5.5.3. Mexico market estimates and forecasts by application, 2013 – 2024
6.6. Middle East & Africa (MEA)
6.6.1. MEA market estimates and forecast, 2013 - 2024
6.6.2. MEA market estimates and forecasts by product, 2013 – 2024
6.6.3. MEA market estimates and forecasts by application, 2013 – 2024
6.6.4. Saudi Arabia
6.6.4.1. Saudi Arabia market estimates and forecast, 2013 - 2024
6.6.4.2. Saudi Arabia market estimates and forecasts by product, 2013 – 2024
6.6.4.3. Saudi Arabia market estimates and forecasts by application, 2013 – 2024
6.6.5. UAE
6.6.5.1. UAE market estimates and forecast, 2013 - 2024
6.6.5.2. UAE market estimates and forecasts by product, 2013 – 2024
6.6.5.3. UAE market estimates and forecasts by application, 2013 – 2024
6.6.6. South Africa
6.6.6.1. South Africa market estimates and forecast, 2013 - 2024
6.6.6.2. South Africa market estimates and forecasts by product, 2013 – 2024
6.6.6.3. South Africa market estimates and forecasts by application, 2013 – 2024
Chapter 7. Company Profiles
7.1. Infa Group
7.1.1. Business overview
7.1.2. Financial data
7.1.3. Product landscape
7.1.4. SWOT analysis
7.1.5. Strategic outlook
7.2. Suzhou Fushilai Pharmaceutical Co., Ltd
7.2.1. Business overview
7.2.2. Financial data
7.2.3. Product landscape
7.2.4. SWOT analysis
7.2.5. Strategic outlook
7.3. MTC Industries, Inc.
7.3.1. Business overview
7.3.2. Financial data
7.3.3. Product landscape
7.3.4. SWOT analysis
7.3.5. Strategic outlook
7.4. Qufu Maidesen Fine Chemical Co., Ltd
7.4.1. Business overview
7.4.2. Financial data
7.4.3. Product landscape
7.4.4. SWOT analysis
7.4.5. Strategic outlook
7.5. Qidu Pharmaceutical Co., Ltd.
7.5.1. Business overview
7.5.2. Financial data
7.5.3. Product landscape
7.5.4. SWOT analysis
7.5.5. Strategic outlook
7.6. Shanghai Shyndec (Modern) Pharmaceutical Co., Ltd.
7.6.1. Business overview
7.6.2. Financial data
7.6.3. Product landscape
7.6.4. SWOT analysis
7.6.5. Strategic outlook
7.7. Jiangsu Tohope Pharmaceutical Company Limited
7.7.1. Business overview
7.7.2. Financial data
7.7.3. Product landscape
7.7.4. SWOT analysis
7.7.5. Strategic outlook
7.8. GeroNova Research, Inc.
7.8.1. Business overview
7.8.2. Financial data
7.8.3. Product landscape
7.8.4. SWOT analysis
7.8.5. Strategic outlook
7.9. Source Naturals, Inc.
7.9.1. Business overview
7.9.2. Financial data
7.9.3. Product landscape
7.9.4. SWOT analysis
7.9.5. Strategic outlook
7.10. HiMedia Laboratories Pvt. Ltd
7.10.1. Business overview
7.10.2. Financial data
7.10.3. Product landscape
7.10.4. SWOT analysis
7.10.5. Strategic outlook
7.11. AlzChem AG
7.11.1. Business overview
7.11.2. Financial data
7.11.3. Product landscape
7.11.4. SWOT analysis
7.11.5. Strategic outlook
7.12. Sabinsa Corporation
7.12.1. Business overview
7.12.2. Financial data
7.12.3. Product landscape
7.12.4. SWOT analysis
7.12.5. Strategic outlook
7.13. Now Health Group Inc.
7.13.1. Business overview
7.13.2. Financial data
7.13.3. Product landscape
7.13.4. SWOT analysis
7.13.5. Strategic outlook
7.14. Life Extension, Inc.
7.14.1. Business overview
7.14.2. Financial data
7.14.3. Product landscape
7.14.4. SWOT analysis
7.14.5. Strategic outlook
7.15. Swanson Health Products, Inc.
7.15.1. Business overview
7.15.2. Financial data
7.15.3. Product landscape
7.15.4. SWOT analysis
7.15.5. Strategic outlook
7.16. Cambridge Commodities Ltd
7.16.1. Business overview
7.16.2. Financial data
7.16.3. Product landscape
7.16.4. SWOT analysis
7.16.5. Strategic outlook
7.17. Toyo Hakko, Co., Ltd
7.17.1. Business overview
7.17.2. Financial data
7.17.3. Product landscape
7.17.4. SWOT analysis
7.17.5. Strategic outlook

Browse full Table of Content @ https://www.gminsights.com/toc/detail/alpha-lipoic-acid-market

About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology

Contact Us
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1 888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com

This release was published on openPR.